These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12903380)

  • 1. NMR analysis of tertiary interactions in HDV ribozymes.
    Tanaka Y; Hori T; Tagaya M; Katahira M; Nishikawa F; Sakamoto T; Kurihara Y; Nishikawa S; Uesugi S
    Nucleic Acids Symp Ser; 2000; (44):285-6. PubMed ID: 12903380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and NMR analysis of HDV ribozymes for structural investigation.
    Tanaka Y; Hori T; Katahira M; Nishikawa F; Sakamoto T; Fukunaga Y; Kurihara Y; Nishikawa S; Uesugi S
    Nucleic Acids Symp Ser; 1999; (42):221-2. PubMed ID: 10780459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imino proton NMR analysis of HDV ribozymes: nested double pseudoknot structure and Mg2+ ion-binding site close to the catalytic core in solution.
    Tanaka Y; Hori T; Tagaya M; Sakamoto T; Kurihara Y; Katahira M; Uesugi S
    Nucleic Acids Res; 2002 Feb; 30(3):766-74. PubMed ID: 11809890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constructing an efficient trans-acting genomic HDV ribozyme.
    Kawakami J; Yuda K; Suh YA; Kumar PK; Nishikawa F; Maeda H; Taira K; Ohtsuka E; Nishikawa S
    FEBS Lett; 1996 Sep; 394(2):132-6. PubMed ID: 8843150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro selection analysis of trans-acting HDV ribozyme.
    Nishikawa F; Chiba A; Shirai M; Fauzi H; Taira K; Kumar PK; Nishikawa S
    Nucleic Acids Symp Ser; 1995; (34):115-6. PubMed ID: 8841579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terbium-mediated footprinting probes a catalytic conformational switch in the antigenomic hepatitis delta virus ribozyme.
    Harris DA; Tinsley RA; Walter NG
    J Mol Biol; 2004 Aug; 341(2):389-403. PubMed ID: 15276831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific modification of functional groups in genomic hepatitis delta virus (HDV) ribozyme.
    Nishikawa F; Shirai M; Nishikawa S
    Eur J Biochem; 2002 Dec; 269(23):5792-803. PubMed ID: 12444967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of an HDV ribozyme which consists of three RNA oligomer strands.
    Sakamoto T; Kuwabara T; Tanaka Y; Kurihara Y; Katahira M; Uesugi S
    Nucleic Acids Symp Ser; 1995; (34):131-2. PubMed ID: 8841587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic characterization of the HDV genomic ribozyme: the cleavage site base pair plays a structural role in facilitating catalysis.
    Cerrone-Szakal AL; Chadalavada DM; Golden BL; Bevilacqua PC
    RNA; 2008 Sep; 14(9):1746-60. PubMed ID: 18658121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparate HDV ribozyme crystal structures represent intermediates on a rugged free-energy landscape.
    Sripathi KN; Tay WW; Banáš P; Otyepka M; Šponer J; Walter NG
    RNA; 2014 Jul; 20(7):1112-28. PubMed ID: 24854621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage reaction of HDV ribozymes in the presence of Mg2+ is accompanied by a conformational change.
    Tanaka Y; Tagaya M; Hori T; Sakamoto T; Kurihara Y; Katahira M; Uesugi S
    Genes Cells; 2002 Jun; 7(6):567-79. PubMed ID: 12059960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nested double pseudoknot is required for self-cleavage activity of both the genomic and antigenomic hepatitis delta virus ribozymes.
    Wadkins TS; Perrotta AT; Ferré-D'Amaré AR; Doudna JA; Been MD
    RNA; 1999 Jun; 5(6):720-7. PubMed ID: 10376872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of the P1.1 pseudoknot is critical for both the cleavage activity and substrate specificity of an antigenomic trans-acting hepatitis delta ribozyme.
    Deschênes P; Ouellet J; Perreault J; Perreault JP
    Nucleic Acids Res; 2003 Apr; 31(8):2087-96. PubMed ID: 12682359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection in vitro of trans-acting genomic human hepatitis delta virus (HDV) ribozymes.
    Nishikawa F; Kawakami J; Chiba A; Shirai M; Kumar PK; Nishikawa S
    Eur J Biochem; 1996 May; 237(3):712-8. PubMed ID: 8647117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of circular permutation on the cis-cleavage reaction of a hepatitis delta virus ribozyme: application to trans-acting ribozyme design.
    Lai YC; Lee JY; Liu HJ; Lin JY; Wu HN
    Biochemistry; 1996 Jan; 35(1):124-31. PubMed ID: 8555165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel structural rearrangement of hepatitis delta virus antigenomic ribozyme.
    Nehdi A; Perreault J; Beaudoin JD; Perreault JP
    Nucleic Acids Res; 2007; 35(20):6820-31. PubMed ID: 17933779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A three-dimensional model of hepatitis delta virus ribozyme based on biochemical and mutational analyses.
    Tanner NK; Schaff S; Thill G; Petit-Koskas E; Crain-Denoyelle AM; Westhof E
    Curr Biol; 1994 Jun; 4(6):488-98. PubMed ID: 7922369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure of the L3 loop from the hepatitis delta virus ribozyme: a syn cytidine.
    Lynch SR; Tinoco I
    Nucleic Acids Res; 1998 Feb; 26(4):980-7. PubMed ID: 9461457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnesium dependence of the amplified conformational switch in the trans-acting hepatitis delta virus ribozyme.
    Tinsley RA; Harris DA; Walter NG
    Biochemistry; 2004 Jul; 43(28):8935-45. PubMed ID: 15248751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The catalytic domain of human hepatitis delta virus RNA. A proton nuclear magnetic resonance study.
    Lee BS; Wu HN; Huang TH
    FEBS Lett; 1993 Jun; 324(3):296-300. PubMed ID: 8405369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.